Ovarian Malignancy Incidence in Moderate Risk Women With Low CA 125
NCT02247323 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2021-02-02
Summary
The investigators are assessing the incidence of ovarian cancer in premenopausal women who were at moderate risk of malignancy with low CA125.
Conditions
Interventions
- OTHER
-
Risk of malignancy index
Calculation of RMI before sugery.
Sponsors & Collaborators
-
Beni-Suef University
lead OTHER
Principal Investigators
-
Nesreen A Shehata, MD · Beni-Suef University
Eligibility
- Min Age
- 45 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-01-31
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Egypt
Study Locations
More Related Trials
-
Observational Retrospective Study on Treatment and Outcomes in Patients With Low-grade Serous Ovarian Cancer
NCT02408536 ·Status: UNKNOWN
-
Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria
NCT06253559 ·Status: COMPLETED
-
Ovarian Cancer Individualized Scoring System Scoring System
NCT05496517 ·Status: UNKNOWN
-
Search for Predictors of Therapeutic Response in Ovarian Carcinoma
NCT01391351 ·Status: COMPLETED ·Phase: NA
-
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
NCT00043472 ·Status: COMPLETED
-
Impact of Different BRCA1/2 Gene Variants on Response to Therapy and Prognosis of Ovarian Cancer
NCT06775470 ·Status: RECRUITING
-
Risk of Ovarian Cancer in Patients With a Pelvic Mass
NCT00315692 ·Status: COMPLETED
-
Contrast-Enhanced Ultrasonography in Diagnosing Early-Stage Ovarian Cancer in Patients With an Adnexal Mass Undergoing Surgery to Remove the Ovary
NCT00626873 ·Status: COMPLETED ·Phase: PHASE1
-
Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
NCT06800105 ·Status: RECRUITING
-
CA-125 in Screening Patients at High Risk for Ovarian Cancer
NCT00080639 ·Status: WITHDRAWN
-
HE4 as a Relapse Biomarker in Ovarian Cancers
NCT02595281 ·Status: COMPLETED ·Phase: NA
-
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
NCT02856841 ·Status: COMPLETED
-
Young Women Diagnosed With Early Stage Ovarian Cancer: A Focus on Fertility Issues and Sexual Function
NCT00525460 ·Status: COMPLETED
-
Skeletal Muscle Energy Metabolism in Women With Weight Loss and Ovarian and/or Endometrial Cancer With Weight Loss
NCT03027479 ·Status: COMPLETED ·Phase: NA
-
Clinical Trial to Screen Participants Who Are at High Genetic Risk for Ovarian Cancer
NCT00039559 ·Status: UNKNOWN ·Phase: NA
-
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
NCT06304922 ·Status: NOT_YET_RECRUITING
-
Observational, Bi-directional (Prospective and Retrospective) Study for Patients With Newly Diagnosed Ovarian Cancer Stages IA to IVB, or Persistent or Recurrent Disease From January 2021; Irrespective of Histology
NCT07167433 ·Status: RECRUITING
-
Assessment of Ovarian Reserve in Female Cancer Survivors
NCT01062542 ·Status: COMPLETED
-
Study of the Impact on Survival of a Paradigm Shift in the Therapeutic Strategy of Patients With Advanced Ovarian Cancer
NCT06907771 ·Status: RECRUITING
-
Early Detection of Relapse in Ovarian Cancer Using Capillary Home-sampling and a Protein Biomarker Test
NCT06445621 ·Status: RECRUITING
-
Assessing Urinary Hormones in Female Cancer Survivors
NCT03197532 ·Status: COMPLETED
-
Live After an Epithelial Ovarian Cancer: Multidisciplinary Assessment of Effects and Long-term Remission in Patients Needs.
NCT02323568 ·Status: COMPLETED ·Phase: NA
-
Endometrial Cancer and Fractalkine-receptor Axis of Fractalkine
NCT02774395 ·Status: COMPLETED
-
The Longitudinal Ovarian Reserve Study
NCT02395341 ·Status: COMPLETED
-
CA125 and Ultrasound in Detecting Ovarian Cancer in Postmenopausal Women
NCT00058032 ·Status: COMPLETED ·Phase: NA